These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 26868492)
1. Lipids and immunoinflammatory pathways of beta cell destruction. Imai Y; Dobrian AD; Morris MA; Taylor-Fishwick DA; Nadler JL Diabetologia; 2016 Apr; 59(4):673-8. PubMed ID: 26868492 [TBL] [Abstract][Full Text] [Related]
2. Expression pattern of 12-lipoxygenase in human islets with type 1 diabetes and type 2 diabetes. Grzesik WJ; Nadler JL; Machida Y; Nadler JL; Imai Y; Morris MA J Clin Endocrinol Metab; 2015 Mar; 100(3):E387-95. PubMed ID: 25532042 [TBL] [Abstract][Full Text] [Related]
3. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes. Donath MY Diabetologia; 2016 Apr; 59(4):679-82. PubMed ID: 26868493 [TBL] [Abstract][Full Text] [Related]
4. MST1: a promising therapeutic target to restore functional beta cell mass in diabetes. Ardestani A; Maedler K Diabetologia; 2016 Sep; 59(9):1843-9. PubMed ID: 27053234 [TBL] [Abstract][Full Text] [Related]
5. Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction. Weaver JR; Holman TR; Imai Y; Jadhav A; Kenyon V; Maloney DJ; Nadler JL; Rai G; Simeonov A; Taylor-Fishwick DA Mol Cell Endocrinol; 2012 Jul; 358(1):88-95. PubMed ID: 22502743 [TBL] [Abstract][Full Text] [Related]
6. Mitochondrial network regulation and its potential interference with inflammatory signals in pancreatic beta cells. Baltrusch S Diabetologia; 2016 Apr; 59(4):683-7. PubMed ID: 26873508 [TBL] [Abstract][Full Text] [Related]
8. 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. Nunemaker CS; Chen M; Pei H; Kimble SD; Keller SR; Carter JD; Yang Z; Smith KM; Wu R; Bevard MH; Garmey JC; Nadler JL Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1065-75. PubMed ID: 18780776 [TBL] [Abstract][Full Text] [Related]
9. 12-Lipoxygenase Products Reduce Insulin Secretion and {beta}-Cell Viability in Human Islets. Ma K; Nunemaker CS; Wu R; Chakrabarti SK; Taylor-Fishwick DA; Nadler JL J Clin Endocrinol Metab; 2010 Feb; 95(2):887-93. PubMed ID: 20089617 [TBL] [Abstract][Full Text] [Related]
10. Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development. Green-Mitchell SM; Tersey SA; Cole BK; Ma K; Kuhn NS; Cunningham TD; Maybee NA; Chakrabarti SK; McDuffie M; Taylor-Fishwick DA; Mirmira RG; Nadler JL; Morris MA PLoS One; 2013; 8(2):e56763. PubMed ID: 23437231 [TBL] [Abstract][Full Text] [Related]
11. A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation. Chang TT; Lin LY; Chen JW Front Immunol; 2021; 12():650626. PubMed ID: 33968046 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli. Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735 [TBL] [Abstract][Full Text] [Related]
14. Targeting 12-lipoxygenase as a novel strategy to combat the effects of inflammation on beta cells in diabetes. Ehses JA; Donath MY Diabetologia; 2015 Mar; 58(3):425-8. PubMed ID: 25537834 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes. Hernandez-Perez M; Chopra G; Fine J; Conteh AM; Anderson RM; Linnemann AK; Benjamin C; Nelson JB; Benninger KS; Nadler JL; Maloney DJ; Tersey SA; Mirmira RG Diabetes; 2017 Nov; 66(11):2875-2887. PubMed ID: 28842399 [TBL] [Abstract][Full Text] [Related]
16. Role of 12-lipoxygenase in decreasing P-cadherin and increasing angiotensin II type 1 receptor expression according to glomerular size in type 2 diabetic rats. Guo QY; Miao LN; Li B; Ma FZ; Liu N; Cai L; Xu ZG Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E708-16. PubMed ID: 21285403 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic beta cell autophagy is impaired in type 1 diabetes. Muralidharan C; Conteh AM; Marasco MR; Crowder JJ; Kuipers J; de Boer P; Linnemann AK Diabetologia; 2021 Apr; 64(4):865-877. PubMed ID: 33515072 [TBL] [Abstract][Full Text] [Related]
18. 12-Lipoxygenase Inhibition on Microalbuminuria in Type-1 and Type-2 Diabetes Is Associated with Changes of Glomerular Angiotensin II Type 1 Receptor Related to Insulin Resistance. Xu HZ; Cheng YL; Wang WN; Wu H; Zhang YY; Zang CS; Xu ZG Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164093 [TBL] [Abstract][Full Text] [Related]
19. Adipose tissue-specific deletion of 12/15-lipoxygenase protects mice from the consequences of a high-fat diet. Cole BK; Morris MA; Grzesik WJ; Leone KA; Nadler JL Mediators Inflamm; 2012; 2012():851798. PubMed ID: 23326022 [TBL] [Abstract][Full Text] [Related]
20. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Donath MY; Böni-Schnetzler M; Ellingsgaard H; Ehses JA Physiology (Bethesda); 2009 Dec; 24():325-31. PubMed ID: 19996363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]